Our team

Co-Founder & CFO
ana.seco @ aptusbiotech.com
Graduate in Economy, MBA IESE Business School, Co-Founder of AptusBiotech and AptaTargets. Expert in Biotech Management. She is the Sole Administrator and Financial Manager of the company.

COO
victor.m.gonzalez @ aptusbiotech.com
Senior researcher at the Ramón y Cajal Institute for Health Research (IRYCIS), where he directs the Aptamer Research Group. PhD in Molecular Biology from the Autonomous University of Madrid.

CSO
miguel.moreno @ aptusbiotech.com
In January 2020 he joined Aptus Biotech as Chief Scientific Officer, where he is responsible of the coordination and monitoring of the different projects of the company, provide scientific support in all R&D&I PhD. in Molecular Biology in 2005 at the University of Alcala de Henares where he developed electrochemical DNA biosensors based on DNA-gold capped nanoparticles. As part of his Master degree, he selected aptamers against a protein of Leishmania infantum. Miguel has worked with Prof. Carlos Martinez A. (CNB-CSIC) and Prof. Laura Lechuga (IMM-CNM-CSIC) developing DNA arrays based on nanocantilevers, as well as with Prof. David Russell at the University of East Anglia (UK) where he was involved in the development of gold nanoparticles as drug carriers for in vivo PDT. In 2007 he co-founded Bioapter, a novel technological company based on the development of aptamers based biosensors and therapies. In October 2009 he joined the Astrobiology Centre in Madrid (CAB, CSIC-INTA) where he was exploring the in vitro selection and evolution of nucleic acids for the development of RNA and DNA aptamers, bionanotechnology-inspired biosensors. He is author of 30 articles in international peer reviewed journals, 5 chapters in specialized books, and more than 70 communications to international conferences.

g.fernandez @ aptusbiotech.com
Graduated in Chemistry, specialty Biochemistry and Molecular Biology (UAM 1997) and PhD. in CC. Chemistry, Biomedicine program (UAH 2002), I have developed my professional career focused on therapy and human diagnosis

Project Manager and Head of Gender Policy
garciasaa @ aptusbiotech.com
Graduated in Chemistry at the Universidad Complutense de Madrid in 1998. She obtained the PH.D degree in 2004 at the Universidad Complutense of Madrid working with genes involved in cell differentiation

Researcher
celia.pinto @ aptusbiotech.com
Degree in Biology (2009), Master of Health Analysis at the Complutense University (2013).and PhD. in Biology at UAH (2019). More than 10 years of experience in aptamers. She has been focused on the development of the aptamer apMNKQ2

Researcher
ana.salgado @ aptusbiotech.com
Graduated in Biology (UAM) and MsC in genetics and cell biology (UAM, UAH, UCM), she is currently undertaking the PhD in Biology at the UAM.She has more than 5 years of experience in aptamers. She owns a CAM Doctor Industrial fellowship

Researcher
laura.herraiz @ aptusbiotech.com
Bachelor in Pharmacy from UCM, MSc in Microbiology by Radboud University (The Netherlands). Experienced researcher in several labs in Germany and The Netherlands.

Researcher
m.barragan @ aptusbiotech.com
Senior Technician in Pathological
Anatomy and Cytology and 7 years of
experience in different aptamer
selection projects.

Director of the Baselga Oncologic Institute (IOB), Clinical Researcher of the Breast Cancer Research Program of the Vall d’Hebrón Oncology Institute of Barcelona. Actively involved in the development of 4 candidates drugs against metastatic breast cancer in Europe from which approved: pertuzumab, eribulina y everolimus. National Prize of Medicine 2021

Leader of the Aptamer Group at IRYCIS. PhD. in Biochemistry at UAM. Postdoctoral researcher at UAH. Expert in aptamers, signalling and molecular biology of cancer as well as ischemic pathologies.